UniProt/SwissProt ID: | LIFR_HUMAN |
Description: | leukemia inhibitory factor receptor alpha [Source:HGNC Symbol;Acc:6597] |
Location: | chr5 p13.1 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S1044 | LVSPDsPRSID | Erk2(MAPK1 | RegPhos |
S1077 | PKDEDsPKSNG | PhosphoSitePlus; HPRD | |
S1044 | LVSPDsPRSID | MAPK_group | phosphoELM; RegPhos |
Y759 | GFLRGyLFYFG | fn3 | PhosphoSitePlus |
Y492 | VENSSyLVALD | fn3 | PhosphoSitePlus |
S1044 | LVSPDsPRSID | MAPK1 | HPRD; phosphoELM |
S1044 | LVSPDsPRSID | MAPK3 | phosphoELM |
Y379 | SFSGKyVRLKR | PhosphoSitePlus | |
S833 | VTKENsVGLII | DUF3827 | PhosphoSitePlus |
Y762 | RGYLFyFGKGE | fn3 | PhosphoSitePlus |
Y974 | TAQVIyIDVQS | PhosphoSitePlus | |
Y369 | PRATSyTLVES | IL6Ra-bind | PhosphoSitePlus |
S927 | DTEIIsPVAER | PhosphoSitePlus; HPRD; phosphoELM; SysPTM | |
S534 | LTTEAsPSKGP | HPRD | |
S490 | KGVENsSYLVA | fn3 | PhosphoSitePlus |
T531 | KQHLTtEASPS | HPRD | |
S1044 | LVSPDsPRSID | PhosphoSitePlus | |
Y807 | QGKTSyHLVLR | fn3 | PhosphoSitePlus |
S491 | GVENSsYLVAL | fn3 | PhosphoSitePlus |
S1044 | LVSPDsPRSID | Erk2 | RegPhos |
S1044 | LVSPDsPRSID | Erk1(MAPK3 | RegPhos |
Y807 | QGKTSyHLVLR | HPRD | |
T530 | KKQHLtTEASP | HPRD | |
Dephosphorylation site |
LIFR_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000263409 | G264S | COSMIC | Skin Cancer | 21984974 |
ENSP00000263409 | F1068L | HPI | Colorectal Cancer | 16959974 |
ENSP00000263409 | D578H | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000398368 | R302H | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000263409 | F1068L | Sjoblom2006, COSMIC | Intestines Cancer | 16959974 |
ENSP00000263409 | I135N | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000398368 | D578H | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000398368 | F1068L | COSMIC | Intestines Cancer | 16959974 |
ENSP00000263409 | R302H | COSMIC | Ovarian Cancer | 21720365 |
ENSP00000398368 | G264S | COSMIC | Skin Cancer | 21984974 |
ENSP00000398368 | F1068L | HPI | Colorectal Cancer | 16959974 |
ENSP00000398368 | I135N | COSMIC | Ovarian Cancer | 21720365 |
Differential expressed protein |
LIFR_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
LIFR_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
MK03_HUMAN | LIFR_HUMAN | kinase -> substrate | Robert H Newman (2013) |
MK01_HUMAN | LIFR_HUMAN | kinase -> substrate | HPRD; Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04630 | Jak-STAT signaling pathway |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005515 | protein binding | IEA | molecular_function |
GO:0005127 | ciliary neurotrophic factor receptor binding | IPI | molecular_function |
GO:0004897 | ciliary neurotrophic factor receptor activity | IDA | molecular_function |
GO:0008284 | positive regulation of cell proliferation | IEA | biological_process |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pat | IDA | biological_process |
GO:0034097 | response to cytokine stimulus | IDA | biological_process |
GO:0007166 | cell surface receptor signaling pathway | TAS | biological_process |
GO:0019221 | cytokine-mediated signaling pathway | IDA | biological_process |
GO:0019838 | growth factor binding | IPI | molecular_function |
GO:0038165 | oncostatin-M-mediated signaling pathway | IDA | biological_process |
GO:0004924 | oncostatin-M receptor activity | IDA | molecular_function |
GO:0005887 | integral to plasma membrane | TAS | cellular_component |
GO:0005576 | extracellular region | IEA | cellular_component |
GO:0004923 | leukemia inhibitory factor receptor activity | IDA | molecular_function |
GO:0048861 | leukemia inhibitory factor signaling pathway | IDA | biological_process |